ch.oddb.org
 
Analyses | Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Ocrevus, Konzentrat zur Herstellung einer Infusionslösung - 
66185001 Roche Pharma (Schweiz) AG
Ocrevus, Konzentrat zur Herstellung einer Infusionslösung20.09.2017
  20.09.2017
Ocrelizumab (L04AA36) 
WHO-DDD19.09.2022
01.99. 
01.99. 
A  
YesMultiple Sklerose
IP 
5324.47Yes
    
10 %5703.60
7680661850010Biotechnologika
7230269 
Composition
ocrelizumabum 30 mg, natrii acetas trihydricus, acidum aceticum glaciale, trehalosum dihydricum, polysorbatum 20, aqua ad iniectabilia q.s. ad solutionem pro 1 ml.
Packungsbestandteile
Concentrate for infusion
Aqua Ad Iniectabilia Q.s. Ad Solutionem
 
Active AgentDose
Ocrelizumabum30 mg/ml
 
Inactive agents
Acidum Aceticum Glaciale
Sodium Acetate Trihydrate
Polysorbatum 20
Trehalosum Dihydricum
Source
Data was imported : 24.10.2017
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
 
2019 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home